The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $99,612.73 firm fixed price purchase order contract to Fraunhofer USA, Inc. to produce ectodomain virus-like particles (VLPs) for the hemagglutinin (HA) molecules of influenza virus strains H1, H3, H5, and H7. The contract was not set aside and has a completion date of June 20, 2018. Fraunhofer USA, Inc. is a non-profit applied research and development organization that has previously received awards from the Department of the Navy and federal grants through the University of Maryland for work in areas such as artificial intelligence testing, human-agent teaming, and aquaculture technology. Fraunhofer USA, Inc. is a division of the larger Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung, a Germany-based non-profit research organization that has also received direct federal contracts and subcontracts for various technical research and development efforts.